These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16416398)

  • 21. Sneddon syndrome and the diagnostic value of skin biopsies - three young patients with intracerebral lesions and livedo racemosa.
    Legierse CM; Canninga-Van Dijk MR; Bruijnzeel-Koomen CA; Kuck-Koot VC
    Eur J Dermatol; 2008; 18(3):322-8. PubMed ID: 18474464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sneddon's syndrome: MR imaging findings.
    Karagülle AT; Karadağ D; Erden A; Erden I
    Eur Radiol; 2002 Jan; 12(1):144-6. PubMed ID: 11868091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gradually progressive dementia without discrete cerebrovascular events in a patient with Sneddon's syndrome.
    Wright RA; Kokmen E
    Mayo Clin Proc; 1999 Jan; 74(1):57-61. PubMed ID: 9987534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathological findings in Sneddon's syndrome.
    Hilton DA; Footitt D
    Neurology; 2003 Apr; 60(7):1181-2. PubMed ID: 12682330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sneddon's syndrome: it is all in the ectoderm.
    Rutter-Locher Z; Chen Z; Flores L; Basu T; Creamer D; Weeks R; Arya R; Nashef L
    Pract Neurol; 2016 Aug; 16(4):300-3. PubMed ID: 26968196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sneddon's syndrome: a case report.
    Lahti J; Yu T; Burnett JW; Lutz L; LaMonte MP; Gunawardane R
    Cutis; 2001 Mar; 67(3):211-4, 220. PubMed ID: 11270293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and neuroradiological aspects of Sneddon's syndrome and primary antiphospholipid antibody syndrome. A follow-up study.
    Fetoni V; Grisoli M; Salmaggi A; Carriero R; Girotti F
    Neurol Sci; 2000 Jun; 21(3):157-64. PubMed ID: 11076004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical characterization of the 'intimal proliferation' phenomenon in Sneddon's syndrome and essential thrombocythaemia.
    Tamm E; Jungkunz W; Wolter M; Marsch WC
    Br J Dermatol; 1994 Dec; 131(6):814-21. PubMed ID: 7857833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiphospholipid antibodies in a female patient with the Sneddon syndrome].
    Rakocević-Stojanović V; Lavrnić D; Pavlović S; Apostolski S
    Vojnosanit Pregl; 1998; 55(4):435-8. PubMed ID: 9769746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein.
    Miyagami M; Katayama Y
    Med Mol Morphol; 2005 Mar; 38(1):36-42. PubMed ID: 16158178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of Sneddon's syndrome associated with Moskowitz's syndrome].
    Belfeki N; Dieudonné L
    Rev Med Liege; 2015 Nov; 70(11):546-9. PubMed ID: 26738265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infarction of the right hemisphere in a patient with antiphospholipid antibody syndrome.
    Finis A; Ssenyonjo H; Knopp U; Koch C; Seidel G; Arnold H; Giese A
    Acta Neurochir (Wien); 2005 Sep; 147(9):997-1002; discussion 1002. PubMed ID: 16041471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Importance of cutaneous biopsy in Sneddon's syndrome].
    González Vilas D; García Gavín J; Sánchez-Aguilar D; Toribio J
    Med Clin (Barc); 2010 Jun; 135(1):44. PubMed ID: 19493550
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sneddon's syndrome].
    El Benaye J; Hsaini Y; Zoobo T; Ghfir M; Bourazza A; Sedrati O
    Presse Med; 2013 Feb; 42(2):138-44. PubMed ID: 22652061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life history of cutaneous vascular lesions in Sneddon's syndrome.
    Zelger B; Sepp N; Schmid KW; Hintner H; Klein G; Fritsch PO
    Hum Pathol; 1992 Jun; 23(6):668-75. PubMed ID: 1592390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sneddon's syndrome: a systemic arterio-occlusive disorder.
    al Meshari K; al Eisa A; Akhtar M
    Am J Kidney Dis; 1995 Aug; 26(2):368-72. PubMed ID: 7645543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations.
    Tu J; Stoodley MA; Morgan MK; Storer KP
    J Neurosurg; 2005 Nov; 103(5):903-9. PubMed ID: 16304995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic imaging features of neurovascular involvement in primary Sneddon's syndrome: an analysis of 12 cases.
    Yilmaz E; Arsava EM; Gocmen R; Oguz KK; Arat A; Topcuoglu MA
    Neurol Sci; 2021 Jun; 42(6):2363-2369. PubMed ID: 33047201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superficial Siderosis and Microbleed Restricted in Cortex Might Be Correlated to Atrophy and Cognitive Decline in Sneddon's Syndrome.
    Yao M; Zhao J; Jiang N; Li L; Ni J
    Front Neurol; 2020; 11():1035. PubMed ID: 33041979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.